CytoDyn to Hold Webcast to Provide a Company Update
CytoDyn to Hold Webcast to Provide a Company Update
CONTACTSVANCOUVER, Washington, April 05, 2023 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Tanya Urbach, Board Chair, Cyrus Arman, President, Antonio Migliarese, Chief Financial Officer, and Scott Hansen, our newly appointed Head of Research and Basic Science, will host an investment community webcast to provide a Company update on Tuesday, April 11, 2023.
溫哥華，華盛頓，2023 年 4 月 5 日（環球美通社）-- 賽托加因股份有限公司 (OTCQB: 賽迪) (「CytodyN」或「公司」), 一個生物技術公司開發 leronlimab, CCR5 拮抗劑與多種治療適應症的潛力, 今天宣布，譚雅, 董事會主席, 賽勒斯·阿曼, 總裁, 安東尼奧·米利亞雷塞, 首席財務官, 和斯科特·漢森, 我們新任命的研究和基礎科學負責人, 將在周二提供一個網絡廣播更新（二零二三年四月十一日）
Following the update, questions submitted prior to the webcast as directed below will be addressed to the extent appropriate.
更新後，在以下網路廣播前提交的問題將在適當的範圍內解決。
| Date: | Tuesday, April 11, 2023 | ||
| Time: | 1:00 pm PT / 4:00 pm ET | ||
| Access: | |||
| Questions: | Please submit any questions prior to the webcast, and not later than Noon PT, Friday, April 7, 2023. Questions can be submitted via email to: ir@cytodyn.com. Per CytoDyn's current policy, the presenters will not be able to take live questions during the webcast. |
| 日期: | 二零二三年四月十一日（星期二） | ||
| 時間: | 太平洋時間下午 1:00 /下午4點 | ||
| 存取： | |||
| 問題: | 請在網路直播前提交任何問題，且不遲於 2023 年 4 月 7 日星期五太平洋時間中午。問題可以通過電子郵件提交到：ir@cytodyn.com。根據 CytodyN 的當前政策, 主持人將無法在網絡廣播過程中採取現場問題. |
This is a livestream presentation. Participants are encouraged to login early prior to the start of the event. The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until May 11, 2023.
這是一個直播演示。我們鼓勵參加者在活動開始前提早登入。此重播將於網路廣播結束後約 60 分鐘開放，並可透過上述連結觀看，直到 2023 年 5 月 11 日為止。
CONTACTS
Investors:
Cristina De Leon
Office: 360.980.8524
ir@cytodyn.com
連絡人
投資者：
克里斯蒂娜·德莱昂
辦公室:
ir@cytodyn.com
